[The effect of oral hypoglycemic agents on the fatty acid composition of liver and depot lipids in rats].
D000273:Adipose Tissue / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*; D000821:Animal Feed; D000818:Animals; D001645:Biguanides / Q000494:pharmacology*; D002849:Chromatography, Gas; D002855:Chromatography, Thin Layer; D005227:Fatty Acids / Q000032:analysis*; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D008055:Lipids / Q000032:analysis*; D008099:Liver / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D009929:Organ Size; D010743:Phospholipids / Q000032:analysis; D051381:Rats; D013997:Time Factors; D014044:Tolbutamide / Q000494:pharmacology*
D001645:Biguanides; D005227:Fatty Acids; D007004:Hypoglycemic Agents; D008055:Lipids; D010743:Phospholipids; D014044:Tolbutamide
Zur Frage der Beeinflussung der Fettsäure-Zusammensetzung der Leber- und Depotlipide durch orale Antidiabetika.